-
Review the number of patients who came through your examination room today, and count how many were screened for one or more sexually transmitted diseases (STDs). If the answer is zero, then perhaps it is time to review your practice guidelines.
-
Your next patient, a 19-year-old woman who is sexually active, says she douches on a weekly basis for hygiene purposes. She has been previously treated for a sexually transmitted disease (STD). What should you tell her?
-
The Washington, DC-based National Abortion Federation (NAF) has launched the first interactive on-line continuing medical education (CME) program to allow health care providers to learn more about mifepristone.
-
Circle your calendar for the upcoming annual Contraceptive Technology Conferences. The San Francisco conference is scheduled for March 12-15, with the Washington, DC, conference set for March 26-29.
-
-
In this prospective cohort study, women who used the copper IUD for emergency contraception had lower unintended pregnancy rates in the following 12 months compared to women who chose the oral levonorgestrel pill.
-
In a large population of older community-dwelling women, there was a strong association between limited motor and balance skills and urge incontinence.
-
A retrospective cohort study of 519 women diagnosed with polycystic ovary syndrome demonstrates that black adolescents and reproductive-aged adults have a higher risk for metabolic syndrome and cardiovascular disease compared to their white counterparts.
-
In a large Norwegian population-based cohort study, women with a history of unilateral oophorectomy experienced a slightly earlier onset of menopause compared to women with both ovaries, but this finding does not suggest a clinically important effect.
-
In this pooled analysis of more than 7700 ovarian cancer patients and nearly 12,000 controls, low-dose aspirin and high-dose non-aspirin NSAID use was associated with a risk reduction for invasive epithelial ovarian cancer of 20-34% relative to non-users. Acetaminophen use was not associated with a risk reduction, irrespective of dose or frequency.
